{"paper_id":"e27e8090-995b-4c90-a27b-2803b9c15392","body_text":"Abstract\nPurpose\nTo compare the effect of hemostatic matrix (HM) and electrosurgical bipolar coagulation (EBC) on ovarian reserve in patients undergoing endometrioma surgery.\nMethods\nThirty patients with single ovarian endometrioma ≥4 cm were randomized to two groups. Ovarian reserve after laparoscopic excision of endometrioma was assessed by serum anti-Müllerian hormone (AMH); preoperatively and in postoperative months 1 and 3.\nResults\nThe preoperative AMH levels were similar between the groups. Intra-group comparisons: the AMH levels were significantly lower in the first and third postoperative months as compared to basal levels in both groups. In each group, AMH levels were significantly higher in the third postoperative month as compared to first postoperative month. Inter-group comparisons: AMH levels were significantly lower in the EBC as compared to the HM at 1st postoperative month (1.64 ± 0.93 vs. 2.72 ± 1.49 ng/mL). However, the AMH levels were increased and became similar at 3rd postoperative month.\nConclusions\nAlthough acute ovarian damage was more in EBC group, ovarian reserve was compensated at 3rd month. Further studies with long-term follow-up will clarify the importance of these findings.\nAccess this article\nWe’re sorry, something doesn't seem to be working properly.\nPlease try refreshing the page. If that doesn't work, please contact support so we can address the problem.\nSimilar content being viewed by others\nReferences\nKitajima M, Defrère S, Dolmans MM et al (2011) Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril 96:685–691\nMohamed ML, Nouh AA, El-Behery MM, Mansour SA (2011) Effect on ovarian reserve of laparoscopic bipolar electrocoagulation versus laparotomic hemostatic sutures during unilateral ovarian cystectomy. Int J Gynaecol Obstet 114:69–72\nRaffi F, Metwally M, Amer S (2012) The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 97(9):3146–3154\nCelik HG, Dogan E, Okyay E, Ulukus C, Saatli B, Uysal S, Koyuncuoglu M (2012) Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimullerian hormone levels. Fertil Steril 97:1472–1478\nEbert AD, Hollauer A, Fuhr N, Langolf O, Papadopoulos T (2009) Laparoscopic ovarian cystectomy without bipolar coagulation or sutures using a gelantine-thrombin matrix sealant (FloSeal): first support of a promising technique. Arch Gynecol Obstet 280:161–165\nAngioli R, Muzii L, Montera R et al (2009) Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol. 16(2):153–156\nFerrero S, Venturini PL, Gillott DJ et al (2012) Hemostasis by bipolar coagulation versus suture after surgical stripping of bilateral ovarian endometriomas: a randomized controlled trial. J Min Inv Gynecol 19:722–730\nBiacchiardi CP, Piane LD, Camanni M et al (2011) Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online 23:740–746\nHwu YM, Wu FSY, Li SH et al (2011) The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Reprod Biol Endocrinol 9:80\nErcan CM, Duru NK, Karasahin KE et al (2011) Ultrasonographic evaluation and anti-mullerian hormone levels after laparoscopic stripping of unilateral endometriomas. Eur J Obstet Gynecol Reprod Biol 158:280–284\nHirokawa W, Iwase A, Goto M et al (2011) The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 26–4:904–910\nLee DY, Kim NY, Kim MJ et al (2011) Effects of laparoscopic surgery on serum anti-mullerian hormone levels in reproductive-aged women with endometrioma. Gynecol Endocrinol 27(10):733–736\nIwase A, Hirokawa W, Goto M et al (2010) Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril 94:2846–2849\nErcan CM, Sakıncı M, Duru NK et al (2010) Antimullerian hormone levels after laparoscopic endometrioma stripping surgery. Gynecol Endocrinol 26(6):468–472\nTsolakidis D, Pados G, Vavilis D et al (2010) The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril 94:71–77\nChang HJ, Han SH, Lee JR et al (2010) Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Mullerian hormone levels. Fertil Steril 94:343–349\nSomigliana E, Berlanda N, Benaglia L et al (2012) Surgical excision of endometriomas and ovarian reserve: a systematic review on serum anti mullerian hormone level modifications. Fertil Steril 98:1531–1538\nAlmog B, Shehata F, Suissa S et al (2011) Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95:2359–2363\nNardo LG, Gelbaya TA, Wilkinson H et al (2009) Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 92:1586–1593\nThemmen AP (2005) Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 34:18–21\nDurlinger ALL, Kramer P, Karels B et al (1999) Control of primordial follicle recruitment by anti- Mullerian hormone in the mouse ovary. Endocrinology 140:5789–5796\nDurlinger AL, Gruijters MJ, Kramer P et al (2002) Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076–1084\nCarlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O (2006) Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21:2223–2227\nParrott JA, Skinner MK (1999) Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 140:4262–4271\nVitt UA, McGee EA, Hayashi M, Hsueh AJW (2000) In vivo treatment with GDF9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 141:3814–3820\nNilsson E, Parrott JA, Skinner MK (2001) Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol Cell Endocrinol 25:123–130\nDissen GA, Romero C, Hirshfield AN, Ojeda SR (2001) Nerve growth factor is required for early follicular development in the mammalian ovary. Endocrinology 142:2078–2086\nSonmezer M, Gungor M, Ensari A, Ortac F (2004) Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor. Int J Gynecol Cancer 14:82–88\nBarboni B, Turriani M, Galeati G et al (2000) Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 63:858–864\nBianco F, Basini G, Grasselli F (2005) Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blocker. Domest Anim Endocrinol 28:308–319\nYoshino O, Osuga Y, Koga K et al (2003) Upregulation of interleukin-8 by hypoxia in human ovaries. Am J Reprod Immunol 50:286–290\nKoga K, Osuga Y, Tsutsumi O et al (2000) Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab 85:3352–3355\nBedaiwy M, El-Nashar S, El-Saman A et al (2008) Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod 23:2709–2717\nBianco F, Basini G, Grasselli F (2005) Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blocker. Domest Anim Endocrinol 28:308–319\nYoshino O, Osuga Y, Koga K et al (2003) Upregulation of interleukin-8 by hypoxia in human ovaries. Am J Reprod Immunol 50:286–290\nKoga K, Osuga Y, Tsutsumi O et al (2000) Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab 85:3352–3355\nConflict of interest\nNone of the authors have a conflict of interest.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nSönmezer, M., Taşkın, S., Gemici, A. et al. Can ovarian damage be reduced using hemostatic matrix during laparoscopic endometrioma surgery? A prospective, randomized study. Arch Gynecol Obstet 287, 1251–1257 (2013). https://doi.org/10.1007/s00404-012-2704-9\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-012-2704-9","source_license":"public-domain-us","license_restricted":false}